ROLE OF ENDOGENOUS INTERLEUKIN‐10 IN LOCAL AND DISTANT ORGAN INJURY AFTER VISCERAL ISCHEMIA‐REPERFUSION
暂无分享,去创建一个
[1] Y. Kotake,et al. Antioxidant Amplifies Antibiotic Protection in the Cecal Ligation and Puncture Model of Microbial Sepsis Through Interleukin-10 Production , 2003, Shock.
[2] C. Dohm,et al. Early Interleukin-10 Treatment Improves Survival and Enhances Immune Function Only in Males After Hemorrhage and Subsequent Sepsis , 2002, Shock.
[3] A. Levine,et al. IL-10 is not protective in intestinal ischemia reperfusion injury. , 2002, The Journal of surgical research.
[4] S. Berceli,et al. Durability of antegrade synthetic aortomesenteric bypass for chronic mesenteric ischemia. , 2002, Journal of vascular surgery.
[5] D. Carter,et al. Characterization of a Murine Model of Endotoxin-Induced Acute Lung Injury , 2002, Shock.
[6] Y. Kotake,et al. Interleukin-10 Overexpression Mediates Phenyl-N-Tert-Butyl Nitrone Protection From Endotoxemia , 2002, Shock.
[7] L. Moldawer,et al. Adenoviral Delivery of Human and Viral IL-10 in Murine Sepsis1 , 2001, The Journal of Immunology.
[8] H. Wong,et al. Absence of endogenous interleukin 10 enhances early stress response during post-ischaemic injury in mice intestine , 2001, Gut.
[9] L. Moldawer,et al. The relationship between visceral ischemia, proinflammatory cytokines, and organ injury in patients undergoing thoracoabdominal aortic aneurysm repair , 2000, Critical care medicine.
[10] L. Moldawer,et al. Interleukin-10 appearance following thoraco-abdominal and abdominal aortic aneurysm repair is associated with the duration of visceral ischaemia. , 2000, European Journal of Vascular and Endovascular Surgery.
[11] L. Moldawer,et al. ANTICYTOKINE THERAPIES FOR ACUTE INFLAMMATION AND THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME: IL‐10 AND ISCHEMIA/REPERFUSION INJURY AS A NEW PARADIGM , 2000, Shock.
[12] Z. Yang,et al. Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. , 2000, Circulation.
[13] A. Lentsch,et al. Interleukin‐10 suppresses hepatic ischemia/reperfusion injury in mice: Implications of a central role for nuclear factor κB , 1999, Hepatology.
[14] L. Moldawer,et al. Exogenously administered interleukin-10 decreases pulmonary neutrophil infiltration in a tumor necrosis factor-dependent murine model of acute visceral ischemia. , 1997, Journal of vascular surgery.
[15] L. Moldawer,et al. Exogenous human recombinant interleukin-10 attenuates hindlimb ischemia-reperfusion injury. , 1997, The Journal of surgical research.
[16] L. Moldawer,et al. VISCERAL ISCHEMIA‐REPERFUSION INJURY PROMOTES TUMOR NECROSIS FACTOR (TNF) AND INTERLEUKIN‐1 (IL‐1) DEPENDENT ORGAN INJURY IN THE MOUSE , 1996, Shock.
[17] K. Rajewsky,et al. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. , 1995, The Journal of clinical investigation.
[18] K. Rajewsky,et al. Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.
[19] C. Valeri,et al. Neutrophil and Nonneutrophil‐Mediated Injury in Intestinal Ischemia‐Reperfusion , 1993, Annals of surgery.
[20] M. Baggiolini,et al. Interleukin‐8, a chemotactic and inflammatory cytokine , 1992, FEBS letters.
[21] T. Espevik,et al. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. , 1986, Journal of immunological methods.
[22] L. Moldawer,et al. Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. , 2002, Critical care medicine.
[23] M. Krangel,et al. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. , 1992, Critical reviews in immunology.